YouTube Facebook LinkedIn Google+ Twitter Xingrss  


Toward Disruption: Transparency in Clinical Trials



April 16, 2013 | Transparency Life Sciences (TLS) is calling for transparency in clinical trials to improve study design, quality and outcomes while drastically reducing costs. Their work is aligning with other industry trends as well. Xconomy
Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.